IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TRIGGIANI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.386
AS - Asia 3.475
EU - Europa 3.146
SA - Sud America 610
AF - Africa 84
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.720
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.239
SG - Singapore 1.270
CN - Cina 1.017
IT - Italia 624
PL - Polonia 496
BR - Brasile 489
DE - Germania 446
HK - Hong Kong 392
UA - Ucraina 380
VN - Vietnam 269
FI - Finlandia 242
FR - Francia 198
GB - Regno Unito 179
RU - Federazione Russa 136
TR - Turchia 136
IN - India 114
BE - Belgio 105
IE - Irlanda 99
CA - Canada 70
MX - Messico 48
BD - Bangladesh 46
ID - Indonesia 45
AR - Argentina 42
CZ - Repubblica Ceca 39
IQ - Iraq 39
ES - Italia 36
NL - Olanda 33
SE - Svezia 31
ZA - Sudafrica 31
JP - Giappone 27
EC - Ecuador 24
CO - Colombia 17
SA - Arabia Saudita 17
MA - Marocco 16
AT - Austria 14
VE - Venezuela 14
GR - Grecia 13
UZ - Uzbekistan 13
LT - Lituania 12
PK - Pakistan 12
AU - Australia 11
DZ - Algeria 11
AE - Emirati Arabi Uniti 9
AL - Albania 8
EG - Egitto 8
HU - Ungheria 8
TN - Tunisia 8
JM - Giamaica 7
BO - Bolivia 6
CL - Cile 6
EU - Europa 6
JO - Giordania 6
PY - Paraguay 6
AZ - Azerbaigian 5
CH - Svizzera 5
IL - Israele 5
KH - Cambogia 5
NP - Nepal 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
LV - Lettonia 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
CY - Cipro 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
BG - Bulgaria 2
GD - Grenada 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
RS - Serbia 2
SI - Slovenia 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CR - Costa Rica 1
ET - Etiopia 1
FJ - Figi 1
GT - Guatemala 1
Totale 14.706
Salva come PNG Salva come JPEG
Città #
Ashburn 877
Singapore 695
Fairfield 691
Warsaw 487
Woodbridge 432
Hong Kong 387
Houston 344
San Jose 322
Seattle 309
Chandler 306
Cambridge 283
Jacksonville 278
New York 268
Wilmington 237
The Dalles 233
Beijing 228
Helsinki 191
Los Angeles 189
Ann Arbor 188
Princeton 163
Dallas 151
Dearborn 140
Brescia 119
Munich 118
Istanbul 103
Lauterbourg 103
Dublin 96
Ho Chi Minh City 90
Leuven 90
Shanghai 79
Nanjing 70
Council Bluffs 68
Milan 62
San Francisco 52
Des Moines 51
Dong Ket 46
Moscow 45
Santa Clara 43
São Paulo 43
Redondo Beach 42
Buffalo 41
Orem 39
Boardman 38
Hanoi 38
San Diego 38
Chicago 36
Frankfurt am Main 34
Jakarta 33
Chennai 31
Denver 31
Washington 31
Montreal 30
Brno 29
London 29
Nanchang 28
Turku 27
Shenyang 26
Brooklyn 25
Changsha 24
Jinan 22
Tokyo 22
Nuremberg 21
Poplar 21
Boston 20
Phoenix 20
Hebei 19
Verona 19
Zhengzhou 19
Johannesburg 18
Baghdad 17
Kunming 16
Mexico City 16
Tianjin 16
Atlanta 15
Brussels 15
Rio de Janeiro 15
Romola 15
Toronto 15
Rome 14
Stockholm 14
Bari 13
Haiphong 13
Barcelona 12
Da Nang 12
Jiaxing 12
Lancaster 12
Ningbo 12
Quito 12
Tashkent 12
Athens 11
Belo Horizonte 11
Naples 11
New Delhi 11
Ribeirão Preto 11
Ankara 10
Brasília 10
Charlotte 10
Düsseldorf 10
Guangzhou 10
Hangzhou 10
Totale 9.921
Salva come PNG Salva come JPEG
Nome #
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 265
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 248
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 246
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 245
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 244
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 225
Pros-IT CNR: an Italian prostate cancer monitoring project 220
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 218
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 212
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 210
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 209
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 205
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 202
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 199
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 190
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 189
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 187
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 181
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 179
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 173
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 172
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 171
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 170
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 169
Role of external beam radiotherapy in the treatment of relapsing meningioma 169
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 168
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 167
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 165
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 164
GUROPA survey: genito-urinary radiation oncology prescription attitudes 162
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 161
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 161
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 160
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 160
From Molecular to Clinical Radiation Biology of Glioblastoma 159
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 159
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 156
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 155
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 154
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 153
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 152
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 147
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 146
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 145
Cetuximab and Radiation Therapy in Head and Neck Cancer 142
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 142
Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy 141
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 139
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 139
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 138
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 138
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 137
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 137
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 136
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 136
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 133
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 132
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 129
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 126
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 126
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 125
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 125
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 125
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 123
Applying radiation protection and safety in radiotherapy 120
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 115
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 111
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 110
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 107
The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT) 107
Letter to the editor regarding “Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable” 106
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 105
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 102
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 102
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 101
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 100
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 100
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 99
Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness 99
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 97
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 97
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study 93
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 91
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 91
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 88
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 83
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 82
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 82
PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 81
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 80
Biological Bases of Immune-Related Adverse Events and Potential Crosslinks With Immunogenic Effects of Radiation 79
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 79
Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: A view of the nation's young oncologists 79
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal's letter to the editor 78
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 77
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 76
SBRT in Lymph-Nodal Oligometastases from Prostate Cancer: Different Outcomes between Pelvic and Para-Aortic Disease 76
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group 76
Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature 76
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy 74
Totale 14.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021537 0 0 0 0 0 0 0 0 0 262 140 135
2021/2022742 65 99 25 28 12 49 30 66 38 82 38 210
2022/2023866 96 35 33 52 88 183 13 105 154 4 64 39
2023/20241.358 69 28 163 74 68 301 49 89 204 47 65 201
2024/20252.257 33 35 29 336 179 206 188 116 248 160 444 283
2025/20264.935 511 608 384 709 617 359 797 206 380 364 0 0
Totale 14.958